Hedge Funds Are Selling BioCryst Pharmaceuticals, Inc. (BCRX)

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shareholders have witnessed a decrease in hedge fund interest lately. This is interesting, because the stock is up big today, after continuing bullishness over its peramivir/FDA letter earlier in the week. So why would hedge funds sell?

To the average investor, there are a multitude of gauges market participants can use to track the equity markets. Some of the most useful are hedge fund and insider trading interest. At Insider Monkey, our studies have shown that, historically, those who follow the top picks of the best hedge fund managers can outclass the S&P 500 by a very impressive margin (see just how much).

Equally as integral, optimistic insider trading sentiment is another way to parse down the stock market universe. There are lots of incentives for a corporate insider to drop shares of his or her company, but only one, very simple reason why they would initiate a purchase. Plenty of empirical studies have demonstrated the useful potential of this tactic if investors understand where to look (learn more here).

Now, it’s important to take a peek at the recent action encompassing BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX).

Hedge fund activity in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

In preparation for this year, a total of 4 of the hedge funds we track were bullish in this stock, a change of -43% from the previous quarter. With hedge funds’ positions undergoing their usual ebb and flow, there exists a few notable hedge fund managers who were upping their stakes meaningfully.

Richard Driehaus

Due to the fact that BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has faced bearish sentiment from hedge fund managers, logic holds that there was a specific group of funds who were dropping their full holdings heading into 2013. At the top of the heap, Richard Driehaus’s Driehaus Capital sold off the biggest stake of all the hedgies we track, comprising close to $3 million in stock., and Jim Simons of Renaissance Technologies was right behind this move, as the fund dropped about less than $1 million worth. These moves are important to note, as aggregate hedge fund interest was cut by 3 funds heading into 2013.

What have insiders been doing with BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)?

Insider purchases made by high-level executives is at its handiest when the company in question has seen transactions within the past 180 days. Over the latest six-month time period, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has experienced 2 unique insiders purchasing, and zero insider sales (see the details of insider trades here).

Let’s also review hedge fund and insider activity in other stocks similar to BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX). These stocks are StemCells Inc (NASDAQ:STEM), EntreMed Inc (NASDAQ:ENMD), Lpath, Inc. (NASDAQ:LPTN), Transition Therapeutics Inc (USA) (NASDAQ:TTHI), and Savient Pharmaceuticals, Inc. (NASDAQ:SVNT). This group of stocks are the members of the biotechnology industry and their market caps are similar to BCRX’s market cap.

Company Name # of Hedge Funds # of Insiders Buying # of Insiders Selling
StemCells Inc (NASDAQ:STEM) 3 0 0
EntreMed Inc (NASDAQ:ENMD) 0 0
Lpath, Inc. (NASDAQ:LPTN) 2 2 0
Transition Therapeutics Inc (USA) (NASDAQ:TTHI) 2 0 0
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) 5 0 5

With the returns shown by Insider Monkey’s research, retail investors should always keep an eye on hedge fund and insider trading sentiment, and BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) applies perfectly to this mantra.

Click here to learn why you should track hedge funds

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!